EcoDrugPlus

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCHYG00000024277
Gene Symbol: MTOR
1 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSCHYG00000001402
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSCHYG00000020674
Gene Symbol: MC3R
1 Cross references
137 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSCHYG00000022195
Gene Symbol: MC4R
1 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSCHYG00000014254
Gene Symbol: MTNR1A
1 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSCHYG00000000114
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCHYG00000006865
Gene Symbol: MME
1 Cross references
234 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSCHYG00000003843
Gene Symbol: MAPT
1 Cross references
226 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSCHYG00000006234
Gene Symbol: MAPK1
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSCHYG00000010214
Gene Symbol: MAPK10
1 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSCHYG00000023279
Gene Symbol: MAPK11
1 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSCHYG00000012865
Gene Symbol: MAPK14
1 Cross references
294 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).